Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Declares Dividend of $84.00

Aerovate Therapeutics, Inc. (NASDAQ:AVTE - Get Free Report) announced a dividend on Wednesday, April 9th, NASDAQ Dividends reports. Shareholders of record on Friday, April 25th will be given a dividend of 84.00 per share on Monday, April 28th. The ex-dividend date is Tuesday, April 29th.

Aerovate Therapeutics Stock Performance

Shares of NASDAQ:AVTE traded up $0.50 during mid-day trading on Friday, reaching $10.00. 220,731 shares of the company's stock were exchanged, compared to its average volume of 17,746. Aerovate Therapeutics has a twelve month low of $43.75 and a twelve month high of $884.98. The firm has a market capitalization of $289.85 million, a price-to-earnings ratio of -3.34 and a beta of 0.95. The business's fifty day moving average price is $2.84 and its 200-day moving average price is $2.64.

Aerovate Therapeutics (NASDAQ:AVTE - Get Free Report) last issued its quarterly earnings results on Friday, April 25th. The company reported ($3.15) earnings per share for the quarter, beating the consensus estimate of ($10.50) by $7.35. Analysts predict that Aerovate Therapeutics will post -2.64 EPS for the current fiscal year.

Aerovate Therapeutics Company Profile

Aerovate Therapeutics, Inc, a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial.